Galera Therapeutics, Inc. · OTC:GRTX
Ikarian Capital, LLC reported a 9.99% stake in Galera Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Ikarian Capital, LLC reported a 9.99% stake in Galera Therapeutics, Inc., 7,538,690 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 7,538,690
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 9.99% | 7,538,690 |
| Neil Shahrestani | 9.99% | 7,538,690 |
Source
Related
- Galera Therapeutics, Inc.
- Ikarian Capital, LLC
- Galera Therapeutics, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Form 4 · Sorensen Mel · Aug 5, 2026
- Form 4 · Chang Nancy T · Aug 5, 2026
- Form 4 · Alleva Lawrence M · Aug 5, 2026
- Form 4 · Friedman Michael R. · Aug 5, 2026
- Schedule 13D · Parvinder Singh Hyare · Jun 11, 2026